Artificial Intelligence (AI) has appeared as a transformative trend in the pharmaceutical manufacturing market. As drug discovery is a time-intensive and costly procedure, the integration of AI has become critical in facilitating the research and development phase. According to the report, AI can potentially facilitate drug discovery times by up to 70%, representing a saving of about US$ 0.5 billion in the process of bringing a new drug to market.
Augmented focus on personalized medicine, the rising prevalence of chronic diseases, and technological advances in drug discovery are shaping the global pharmaceutical manufacturing market. Also, regulatory guidelines and patent expiration of blockbuster drugs have led to the burgeoning generics market, which is expected to reach US$ 574 billion by 2030. In addition to this, according to the research report of Astute Analytica, the global pharmaceutical manufacturing market is growing at a compound annual growth rate (CAGR) of 11.56% during the forecast period from 2024 to 2032.
The role of AI and ML in pharmaceutical manufacturing is: -
AI can be programmed to take up several functions but is only limited by nature and the limitations of its programming. In the pharmaceutical industry, the basics of drug manufacturing dictate that the company must produce drugs in high quantities to be advantageous and recoup development costs. However, this needs scalability and efficiency at every step of the manufacturing procedure. Incorporating ML and AI in pharmaceutical manufacturing can handle most of these problems.
ML and AI can bring efficiency to every step of the procedure starting from research and development to manufacturing and distribution. It can curb shortages by forecasting demand utilizing predictive AI. It is even possible to optimize supply chains with real-time visibility of speed, shipment location, and movement, which can be matched with traffic and weather condition data to predict the right route and an accurate ETA for warehouses. The application of AI in pharma manufacturing also has several other benefits: -
Efficient Quality Assurance and Regulatory Compliance
AI can assist in spotting shortcomings in raw materials even before they enter the production line and thus, main quality and regulatory compliance. Moreover, IoT associated with AI technology is helping manufacturers spot faulty packaging, products, and machinery.
Predictive Quality Analytics (PQA) To Optimise the Production Process
Several pharmaceutical manufacturers are making utilize of Industry 4.0 solutions like advanced analytics and automation. Such solutions automated process control systems. The analyses the vast scale of data obtained during the production procedure and applies advanced data analytics and machine learning to derive crucial insights. This allows manufacturers to determine bottlenecks in the process and eliminate unneeded hurdles; thus, leading to cheaper and more optimized production.
Enhances Batch Manufacturing Procedure
Transfer of data and knowledge from different sources is helping manufacturers enhance the batch drug-making process via optimized resource utilization. From predicting different resources required for a drug to forecasting the best schedule for manufacturing it, AI offers the best drug manufacturing configuration with minimal waste.
Fostering Continuous Process Verification
As multiple systems in the pharmaceutical industry churn out a huge amount of data, it can be challenging for manufacturers to stay on top of their function verification reporting. ML and AL-based solutions come equipped with contextualization abilities and deep learning to mitigate the issue with data integration, standardization, and analysis, thus allowing a continuous process verification (CPV) environment.
